CDTX vs CVS · rev $1.3M vs P/E 16, rev $402.07B
Cidara Therapeutics Inc (CDTX) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CDTX currently screens at market cap $6.96B. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the CDTX and CVS stock pages for the full models.
Not investment advice.